ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Berberrubine is a novel and selective IMPDH2 inhibitor that impairs the growth of colorectal cancer

He, Xiangli; Cui, Jiayan; Ma, Hui; Abuduaini, Naijipu; Huang, Ying; Tang, Lu; Wang, Wanyan; Zhang, Yuanyuan; Wang, Yang; Lu, Weiqiang*; Feng, Bo*; Huang, Jin*复旦大学; 华东理工大学; 上海交通大学; 5
Biochemical Pharmacology2023-12DOI: 10.1016/j.bcp.2023.115868
3阅读
引用收藏
分享

摘要

Inosine monophosphate dehydrogenase (IMPDH) catalyzes the rate-limiting reaction in the de novo synthesis pathway of guanine nucleotides that is highly required for cancer cell outgrowth. Herein, we found that IMPDH isoform 2 (IMPDH2) is highly expressed in colorectal cancer (CRC) and is correlated with poor patient prognosis. Via structure-based virtual screening, we identified berberrubine, a critical ingredient of the medical plant Coptis chinensis, as a novel, selective, and competitive inhibitor of IMPDH2, which demonstrated over 15-fold selectivity to IMPDH2 than IMPDH1. Besides, we also confirmed the interaction between berberrubine and IMPDH2. Of note, berberrubine treatment significantly impairs the growth of human CRC cells in a dose-dependent manner, which can be rescued by supplementing with guanosine. Furthermore, oral administration of berberrubine remarkably reduced tumor volume and weight in a human cell line-derived xenograft model. Importantly, the anti-cancer activity of berberrubine was also confirmed by using the azoxymethane (AOM) / dextran sulfate sodium (DSS)-induced spontaneous CRC mouse model. Taken together, our study highlights that berberrubine acts as a novel IMPDH2 inhibitor, suppressing the growth of CRC in vitro and in vivo, providing a fresh perspective for its potential application in the treatment of CRC.

学科与关键词

关键词
Colorectal cancerIMPDH2BerberrubineNatural products
相关
加载中…
  • Berberine inhibits tumour growth in vivo and in vitro through suppressing the lincROR-Wnt/β-catenin regulatory axis in colorectal cancer
    Li, Shi-ying; Shi, Chuan-jian; Fu, Wei-ming; Zhang, Jin-fang*Journal of Pharmacy and Pharmacology, 2023, 75(1): 129-138.被引 3
  • Decylubiquinone Inhibits Colorectal Cancer Growth Through Upregulating Sirtuin2
    Li, Jinlian; Zheng, Shuting; Cheng, Ting; Li, Yuanyuan; Mai, Xiaobin; Jiang, Guangchun; Yang, Yongxia; Zhang, Qianqian; Li, Jiangchao; Zheng, Lingyun; Wang, Lijing*; Qi, Cuiling*Frontiers in Pharmacology, 2022, 12: 804265.被引 2
  • Characterizing the Antitumor Effect of Coptis chinensis and Mume Fructus against Colorectal Cancer Based on Pharmacological Analysis
    Gao, RuiJiao; Lv, Ying*Evidence-based Complementary and Alternative Medicine, 2022, 2022: 9061752.被引 4
查看全部 →

发表信息

论文状态
公开发表
期刊
Biochemical Pharmacology
发表日期
2023-12
卷期
第 218 卷
页码
115868
DOI
10.1016/j.bcp.2023.115868
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81973362]; Shanghai Frontiers Science Center of Optogenetic Techniques for Cell Metabolism (Shanghai Municipal Education Commission); Guangdong Medical Science and Technology Research Foundation [SKLDR-2023-KF-04]; State Key Laboratory of Drug Research 2023 Open project [03-28]; [B2021077]

作者

  • H

    He, Xiangli (第一作者)

    east china univ sci & technol

  • C

    Cui, Jiayan

    east china univ sci & technol

查看全部 12 位作者收起作者
  • M

    Ma, Hui

    east china univ sci & technol

  • A

    Abuduaini, Naijipu

    ruijin hosp · shanghai jiao tong univ

  • H

    Huang, Ying

    guangdong inst drug control

  • T

    Tang, Lu

    east china univ sci & technol

  • W

    Wang, Wanyan

    east china univ sci & technol

  • Z

    Zhang, Yuanyuan

    east china univ sci & technol

  • W

    Wang, Yang

    5 · fudan univ

  • L

    Lu, Weiqiang (通讯)

  • F

    Feng, Bo (通讯)

    ruijin hosp · shanghai jiao tong univ

  • H

    Huang, Jin (通讯)

    east china univ sci & technol

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417